PANAXIA LABS ISRAEL LTD Inactive Instrument
Panaxia Labs Israel Ltd Stock TEL AVIV STOCK EXCHANGE
Equities
PNAX
IL0011043630
Investment Management & Fund Operators
| Sales 2022 | 39.42M 10.78M | Sales 2023 | 19.59M 5.36M | Capitalization | 22.44M 6.14M |
|---|---|---|---|---|---|
| Net income 2022 | -43M -11.76M | Net income 2023 | -13M -3.56M | EV / Sales 2022 | 1.63 x |
| Net Debt 2022 | 36.12M 9.88M | Net Debt 2023 | 36.1M 9.88M | EV / Sales 2023 | 2.99 x |
| P/E ratio 2022 |
-0.65
x | P/E ratio 2023 |
-1.69
x | Employees | - |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 40.67% |
More Fundamentals
* Assessed data
More news
More press releases
| Managers | Title | Age | Since |
|---|---|---|---|
Dadi Segal
CEO | Chief Executive Officer | 48 | 19-09-30 |
Assi Rotbart
CHM | Chairman | 49 | 19-09-30 |
| Director of Finance/CFO | 66 | 22-12-27 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Michal Yageel
BRD | Director/Board Member | 54 | 21-12-28 |
Tal Yaron Eldar
BRD | Director/Board Member | 60 | 16-07-20 |
Michal Sapir
BRD | Director/Board Member | 66 | 22-03-16 |
Barak Investment House Ltd, formerly known as Panaxia Labs Israel Ltd, is an Israel-based company that is active in financial industry. Barak Investment House Ltd deals with investment fund management and investment portfolio management.
| 1st Jan change | Capi. | |
|---|---|---|
| +28.46% | 94.45B | |
| -5.56% | 93.86B | |
| +22.78% | 28.43B | |
| -1.27% | 18.7B | |
| +9.49% | 16.03B | |
| +16.15% | 15.8B | |
| -21.69% | 12.27B | |
| +29.33% | 10.03B | |
| +19.07% | 9.81B |
